Safety and Tolerability of Low-Dose Temozolomide During Whole Brain Radiation in Patients With Cerebral Metastases From Non-Small-Cell Lung Cancer (Study P04071)(TERMINATED)
Clinical trial NCT00266812 · TERMINATED
Trial details
- NCT number
- NCT00266812
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-03-08
- Primary completion
- 2008-01-16
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.